Phase II study of fludarabine, cytarabine (ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders

Apostolia M. Tsimberidou, Susan M. O'Brien, Jorge E. Cortes, Stefan Faderl, Michael Andreeff, Hagop M. Kantarjian, Michael J. Keating, Francis J. Giles*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of fludarabine, cytarabine (ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders'. Together they form a unique fingerprint.

Medicine & Life Sciences